Two Sigma Advisers’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,100
| Closed | -$190K | – | 2340 |
|
|
2025
Q1 | $190K | Buy |
25,100
+3,200
| +15% | +$24.2K | ﹤0.01% | 2152 |
|
|
2024
Q4 | $267K | Buy |
21,900
+4,000
| +22% | +$48.7K | ﹤0.01% | 2027 |
|
|
2024
Q3 | $300K | Sell |
17,900
-2,900
| -14% | -$48.5K | ﹤0.01% | 1908 |
|
|
2024
Q2 | $363K | Buy |
20,800
+1,200
| +6% | +$20.9K | ﹤0.01% | 2001 |
|
|
2024
Q1 | $334K | Sell |
19,600
-19,000
| -49% | -$324K | ﹤0.01% | 2030 |
|
|
2023
Q4 | $393K | Buy |
+38,600
| New | +$393K | ﹤0.01% | 2010 |
|
|
2022
Q4 | – | Sell |
-15,000
| Closed | -$192K | – | 2529 |
|
|
2022
Q3 | $192K | Buy |
+15,000
| New | +$192K | ﹤0.01% | 2214 |
|